Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Usefulness of immunohistochemistry for recognizing metastatic colorectal adenocarcinoma in infarcted lymph nodes.

Kojima M, Nakamura S, Shimizu K, Iijima M, Saruki N, Sakata N, Masawa N.

Pathol Res Pract. 2005;200(11-12):771-4.

PMID:
15792119
2.
3.

Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.

García-Sáenz JA, Sáenz MC, González L, Pérez-Segura P, Puente J, López-Tarruella S, Sastre J, Casado A, López-Asenjo JG, Díaz-Rubio E.

Clin Transl Oncol. 2006 Sep;8(9):676-80.

PMID:
17005470
4.

Metastatic potential in T1 and T2 colorectal cancer.

Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1688-91.

PMID:
16334758
5.

Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.

Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, Hardingham JE.

Dis Colon Rectum. 2004 May;47(5):679-86.

PMID:
15037935
6.
7.

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.

Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A.

Pathology. 2011 Feb;43(2):133-7. doi: 10.1097/PAT.0b013e3283425b7f.

PMID:
21233674
8.
9.

Lymph node infarction: role of underlying malignancy, tumour proliferation fraction and vascular compromise--a study of 35 cases and a comprehensive review of the literature.

Jiang XS, West DS, Lagoo AS.

Histopathology. 2013 Jan;62(2):315-25. doi: 10.1111/j.1365-2559.2012.04361.x. Review.

PMID:
23020754
10.

Immunohistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma.

Tokunaga N, Kijima H, Noto T, Osamura Y, Sadahiro S, Tajima T, Mitomi T.

Dis Colon Rectum. 1995 Aug;38(8):842-7.

PMID:
7543404
11.

The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.

Davies M, Arumugam PJ, Shah VI, Watkins A, Roger Morgan A, Carr ND, Beynon J.

Clin Transl Oncol. 2008 Mar;10(3):175-9.

PMID:
18321821
12.
13.
14.

Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2.

Shimoyama M, Yamazaki T, Suda T, Hatakeyama K.

Dis Colon Rectum. 2003 Mar;46(3):333-9.

PMID:
12626908
15.

Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.

Yasuda K, Inomata M, Shiromizu A, Shiraishi N, Higashi H, Kitano S.

Dis Colon Rectum. 2007 Sep;50(9):1370-6.

PMID:
17661146
16.
17.

Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.

Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.

Pol J Pathol. 2011;62(1):19-24.

18.

Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.

D'Cunha J, Corfits AL, Herndon JE 2nd, Kern JA, Kohman LJ, Patterson GA, Kratzke RA, Maddaus MA.

J Thorac Cardiovasc Surg. 2002 Mar;123(3):484-91; discussion 491.

19.

Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma.

Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K.

Virchows Arch. 2006 Jun;448(6):763-7.

PMID:
16570180
20.

Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.

D'Armento G, Daniele L, Mariani S, Ottaviani D, Mussa A, Cassoni P, Sapino A, Bussolati G.

Int J Surg Pathol. 2009 Apr;17(2):93-8. doi: 10.1177/1066896908328574.

PMID:
19074466
Items per page

Supplemental Content

Support Center